AzTrials
AzTrials

Depressed MoodNCT07903896

Heat and Mental Health - PART 2

A study testing Heat/Humidity Exposure Condition and Thermoneutral Condition in people with Depressed Mood and Young Adults, run by Hartford Hospital at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn how hot indoor temperatures affect mood in young adults with depression, with or without anxiety. It will also explore whether the time of day the heat happens matters, and whether changes in sleep, thinking, and daily activity help explain the effect. Read more about this study

Who is it for?
Ages 18 to 25 years
Conditions the study is for
Depressed Mood, Young Adults, Heat Stress
What is being tested?
Heat/Humidity Exposure Condition and Thermoneutral Condition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
1 siteUnited States
Study dates
Oct 2026to Sep 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • 18 ≥ age ≤ 25 at time of consent
  • has current depression as measured by a PHQ-9 score >9 and corroborated by the DIAMOND Diagnostic Interview
  • resides within 75 mi. of Yale Biobehavioral Laboratory
  • willing/able to travel up to 75 mi. each way by car from their home to the Yale Biobehavioral Laboratory and back to their home
  • speaks/reads English fluently (surveys, interviews, and study measures are only validated in English; translating materials without proper validation could lead to responses that are not truly comparable, threatening reliability; limitations in budget, staffing, and available interpreters prevent the use of translated materials or hiring sufficient bilingual team members)
  • any gender
Show all 9Show fewer
  • any race/ethnicity
  • able (have capacity)/willing to sign informed consent form (ICF)
  • has reliable access to a smartphone

Who cannot join

  • age <18 or age ≥26 at time of consent
  • does not have current depression as indicated by a PHQ-9 score <9
  • does not reside within 75 mi. of Yale Biobehavioral Laboratory
  • not willing/able to travel up to 75 mi. each way by car from their home to the Yale Biobehavioral Laboratory and back to their home
  • does not speak/read English fluently
  • unable (not have capacity)/unwilling to sign informed consent form (ICF)
Show all 18Show fewer
  • has a job that requires rotating shifts and/or works 2nd or 3rd shift (i.e., night shifts) that affect circadian rhythm and sleep architecture
  • planned air travel between time zones during the study period that is likely to affect circadian rhythm
  • does not have reliable access to a smartphone
  • is pregnant or lactating
  • has a recent history (hospital admission within 2 years) of heat-related illness (e.g. heat stroke, heat exhaustion, or rhabdomyolysis)
  • weight < 40 kg (88 lbs) - minimum body weight requirement
  • has a motility disorder of the gastrointestinal tract
  • has undergone surgical procedures in the gastrointestinal tract
  • has known swallowing disorders or dysphagia
  • has any condition that affects normal digestive function (GERD requiring treatment; Barrett's esophagus; achalasia or esophageal stricture; gastroparesis; IBS; inflammatory bowel disease (Crohn's disease or ulcerative colitis); celiac disease; microscopic colitis; chronic constipation or chronic diarrhea; malabsorption syndromes (e.g., pancreatic insufficiency, bile acid malabsorption); chronic liver disease; chronic pancreatitis; symptomatic gallbladder or post-cholecystectomy syndrome; prior bariatric surgery or bowel resection with ongoing effects; ostomy; chronic motility disorders; diabetes with autonomic neuropathy; neurologic or systemic diseases affecting GI function (e.g., Parkinson's disease, multiple sclerosis, scleroderma); chronic medication-induced GI dysfunction; eating disorders affecting digestion or nutrition.
  • has any condition that affects the body's ability to regulate temperature, including, Neurological conditions (such as spinal cord injuries, multiple sclerosis, traumatic brain injury, Guillain-Barré syndrome); Endocrine/metabolic disorders (such as hyperthyroidism/hypothyroidism, Type 1 or 2 diabetes, and anorexia nervosa); Cardiovascular conditions (such as Reynaud's disease, hypertrophic cardiomyopathy, and congenital heart); Dermatological conditions, (such as anhidrosis or hyperhidrosis and extensive burns or scarring associated with trauma).
  • engage in regular alcohol use (>2 drinks per day), daily cannabis use, or any illicit drug use which can affect sleep architecture

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Isaac C McAlister, PhD contact

860-545-7231

Isaac.McAlister@hhchealth.org

Joshua R Wortzel, MD, MPhil, MS(Ed) contact

860-545-7084

Joshua.Wortzel@hhchealth.org

United States1 site, 1 recruiting
  • Yale Biobehavioral and Translational Research Center

    Orange, Connecticut, 06477

    Monica Ordway, PhD, APRN, PPCNP-BC, FAAN, 203-737-5354, monica.ordway@yale.edu

    Sarah Linsky, sarah.linsky@yale.edu

    Recruiting

Other trials in United States

About this study

Official title: Heat Effects on Mental Health in Young Adults (HEAT-MIND Lab PART 2)

The goal of this clinical trial is to learn how hot indoor temperatures affect mood in young adults with depression, with or without anxiety. It will also explore whether the time of day the heat happens matters, and whether changes in sleep, thinking, and daily activity help explain the effect.

The main questions it aims to answer are:

Read more
  • Does heat during the day affect mood differently than heat at night?
  • Do changes in sleep, thinking, or activity help explain those effects? Researchers will compare a weekend that is hot during the day to a weekend that is hot at night to see how the timing of heat affects mood.

Participants will take part for about four weeks. During that time, participants will:

  • Stay in a sleep lab for two weekends, two weeks apart. Each stay runs from Friday afternoon to Monday midday.
  • Spend one weekend in rooms that are hot (32°C, or 90°F) from 8 in the morning to 8 at night, and comfortable (22°C, or 72°F) overnight
  • Spend the other weekend in rooms that are comfortable (22°C, or 72°F) during the day and hot (32°C, or 90°F) overnight
  • Be woken up at 2 in the morning on the last night of each lab stay. Participants will answer questions and do short thinking tasks, then go back to sleep.
  • Wear sensors that track their sleep, heart rate, and body temperature, and swallow a small capsule that measures body temperature from the inside
  • Answer questions about their mood and do short thinking tasks, both in the lab and at home
  • Use a phone app for the whole four weeks of the study. The app asks about mood and sleep, and works with the sensors to track sleep, movement, heart rate, temperature, and humidity.
Read the detailed description

BACKGROUND AND RATIONALE Rising ambient temperatures are associated with worsening mood outcomes, and young adults with depressive disorders may be particularly susceptible. The mechanisms underlying this association remain poorly characterized. Three candidate pathways are measurable and potentially modifiable: sleep-wake disturbance, impaired cognitive performance, and reduced physical activity. Establishing whether these pathways carry the effect of heat on mood would identify targets for intervention that do not require modifying the thermal environment itself, which is often less modifiable.

A central and under-examined question is whether the timing of heat exposure matters. Nocturnal heat is hypothesized to act principally through sleep disruption, whereas daytime heat may act through effects on activity, cognition, and direct thermal discomfort. Distinguishing these requires an experimental contrast in exposure timing rather than a comparison between heat and its absence. Alongside affective outcomes, the study examines anger, aggression, and prosocial versus antisocial behavior, domains with an established association with ambient heat but limited experimental characterization in clinical populations.

RELATIONSHIP TO COMPANION OBSERVATIONAL STUDY This trial is conducted alongside a companion observational study within the same research program, Heat Effects on Mental Health in Young Adults (HEAT-MIND Lab PART 1), in which young adults are monitored while in their home environments across the summer months without assignment of any exposure. The observational study characterizes naturally occurring heat exposure and its association with sleep, mood, cognition, and activity in real-world conditions; while the present trial establishes directionality under controlled exposure. The two studies share a subset of monitoring instrumentation and measurement definitions, supporting comparison between experimentally controlled and naturalistic findings. PART 1 involves no assignment of interventions by the investigators and is reported separately.

STUDY DESIGN AND EXPOSURE This is a randomized, counterbalanced crossover study in which each participant serves as their own control across two laboratory weekends separated by two weeks. The two conditions are matched for total heat exposure and differ only in its timing.

In the daytime-heat condition, ambient temperature is maintained at 32°C from 08:00 to 20:00 and at 22°C overnight. In the nighttime-heat condition, this schedule is reversed. Absolute humidity is held constant at approximately 13 g/m³ across both conditions and both temperatures. Temperature and humidity are monitored continuously throughout both laboratory weekends.

Because both conditions contain heat, this design does not include a thermoneutral control arm. The contrast of interest is the differential effect of heat timing, and the exposure-matched structure removes total thermal load as a competing explanation for observed differences between weekends.

CONTINUOUS MONITORING PERIOD Individual participation spans 28 days. Ecological momentary assessment and wearable monitoring run continuously across this entire period, including during both laboratory weekends, using the HEAT-MIND mobile application (Avicenna Research) in combination with wearable sensors. Continuous monitoring captures repeated assessment of mood, anxiety, anger and aggression, cognitive performance, daily sleep diaries, wrist actigraphy, heart rate, ambient light exposure, and ambient temperature and humidity in the participant's own environment. This design permits each laboratory weekend to be interpreted against the participant's own preceding and following real-world baseline rather than against a single pre-study assessment.

Pre-laboratory sleep schedules and dietary intake are not controlled. This is a deliberate design choice grounded in the translational aims of the study: the research question concerns how real-world heat exposure affects young adults with depression against the background of their usual routines. Pre- and post-laboratory home-monitoring data (e.g., sleep duration, timing, physical activity, and environmental exposures) will be incorporated as model covariates and in sensitivity analyses of within-participant differences between the two laboratory weekends.

LABORATORY PROCEDURES AND MEASUREMENT Laboratory weekends are conducted at the Yale Biobehavioral Sleep Laboratory at the Yale School of Nursing, with participants resident from Friday afternoon through Monday midday, spanning three nights.

Overnight sleep is assessed by 18-channel attended polysomnography, including electroencephalography, electrooculography, electromyography, electrocardiography, respiratory inductance plethysmography, and airflow and thermistor channels, with concurrent wrist actigraphy.

Separately, waking neurophysiology is assessed by high-density electroencephalography using a 128-lead saline cap, administered at multiple timepoints across each weekend. This approximately 30-minute protocol comprises resting-state recording as well as auditory and visual oddball paradigms, supporting assessment of hypofrontality and functional connectivity in the Default Mode and Salience networks under each thermal condition.

On the final night of each laboratory weekend, participants are awakened at 02:00 for a scheduled nocturnal assessment comprising an additional ecological momentary assessment battery while being monitored through polysomnographic electroencephalography. This procedure allows mood, cognitive performance, and hypofrontality to be characterized during nocturnal wakefulness under each thermal condition. Because it occurs on the final night of both weekends, the procedure is symmetric across conditions and does not differentially perturb one exposure relative to the other.

Personal peripheral and core temperature measurement is continuous. Core body temperature is measured using an ingestible telemetric capsule (e-Celsius), peripheral temperature by iButton sensors (6 locations), and ambient temperature and humidity by fixed and portable environmental monitors (Kestrel Drop and SwitchBot IP65). Under-covers temperature and humidity are also measured with an iButton while participants are in bed, characterizing the sleep microenvironment, which may diverge from room-level conditions. Continuous heart rate is collected in parallel and additionally serves as a validated surrogate for core temperature, providing continuity in the event of capsule failure or early voiding and permitting internal cross-validation between measured and estimated core temperature within the sample.

Behavioral and affective assessment during laboratory weekends includes a semi-structured qualitative interview conducted by a research assistant on the final morning. The qualitative component provides participant-reported context on the experience of each exposure condition.

Cognitive tasks and measurements of mood and depression severity are administered via ecological momentary assessment.

STANDARDIZATION OF THE LABORATORY ENVIRONMENT While the pre-laboratory period is intentionally naturalistic, the laboratory environment is tightly standardized and held consistent across a participant's two weekends. Meals are provided on a fixed schedule, with calorie-counted meals and snacks, post-meal photography to estimate consumption, and documentation of additional intake. Bedding, sleepwear, and room furnishings are standardized. Lighting practices are held constant across weekends, including consistent overhead lighting, yellow-shifted emergency lighting overnight, and consistent management of the common-area window during evening and overnight periods; bedrooms have no windows. Ambient light exposure is additionally measured continuously by wearable photometric sensors (ActLumus), permitting light conditions to be characterized analytically rather than assumed constant.

Because participants are studied in the same physical environment under the same schedule across both weekends, stable features of the setting are not expected to bias one exposure condition relative to the other.

SAFETY MONITORING The study is overseen by an independent Data Safety Monitoring Board. Physician coverage during laboratory weekends is divided by call type, with heat-related clinical questions directed to a sleep medicine physician and psychiatric questions directed to a psychiatrist. Participants undergo alcohol and substance use screening at the outset of each laboratory weekend; and hydration is assessed via urine refractometry both at the weekend's outset and twice daily throughout the weekend, with a rehydration protocol in place if dehydration is noted (urine specific gravity >1.020).

STAKEHOLDER INVOLVEMENT Young adults with lived experience of mood disorders contributed to protocol development. A nationally recruited group of lived experience experts will participate in developing multimedia materials communicating findings to peers.

Being tested
Heat/Humidity Exposure Condition, Thermoneutral Condition
Keywords
heat stress, depression, sleep, young adult, mood, temperature, mental health, laboratory, EMA, summer, physical activity, cognition
Medical subject headings
Consciousness Disorders, Heat Stress Disorders, Depression, Psychological Well-Being, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heat/Humidity Exposure ConditionOther

    • Ambient temperature within the laboratory is set to 32 degrees Celsius (~90 F)
    • Ambient humidity is set to ~13g/m³
  • Thermoneutral ConditionOther

    • Ambient temperature within the laboratory is set to 22 degrees Celsius (~72 F)
    • Ambient humidity is set to maintain ~13g/m³
Study groups in NCT07903896
Study groupRoleWhat they receive
Sequence A: Cool Days-Hot NightsExperimentalSubjects exposed to thermoneutral conditions during the day on Saturday; followed by hot/humid conditions during the night on Saturday night; followed by thermoneutral conditions during the day on Sunday; followed by hot/humid conditions during the night on Sunday night.
Receives: Other: Heat/Humidity Exposure Condition; Other: Thermoneutral Condition
Sequence B: Hot Days-Cool NightsExperimentalSubjects exposed to hot/humid conditions during the day on Saturday; followed by thermoneutral conditions during the night on Saturday night; followed by hot/humid conditions during the day on Sunday; followed by thermoneutral conditions during the night on Sunday night.
Receives: Other: Heat/Humidity Exposure Condition; Other: Thermoneutral Condition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PANAS-10

    EMA Mood 10 items 5-pt Likert Score: 10-50

    Measured: periprocedurally* measures collected during lab weekends (i.e. periprocedurally) ONLY - marked with " * "

  2. POMS-8 [depression subscale of POMS-60]

    EMA Depressed Mood 8 items 5-pt Likert Score: 0-32

    Measured: periprocedurally*

  3. PHQ-9

    EMA Depressed Mood 9 items 4-pt Likert Score: 0-27

    Measured: baseline, pre-intervention, periprocedurally

  4. GAD-7

    EMA Anxious Mood 7 items 4-pt Likert Score: 0-21

    Measured: baseline, pre-intervention, periprocedurally

  5. Qualitative Experience

    In-person interview

    Measured: immediately after intervention*

Secondary outcomes (7)
  1. Sleep Self Assessment

    Audio-diary

    Measured: pre-intervention, periprocedurally

  2. Sleep Monitoring

    1. Sleep Stages (times, duration) - est. from Heart Rate (BPM) + Movement. Stages = Light, Deep, REM ii) Time Asleep \& Time in Bed iii) Time Awake \& Restlessness

    Measured: pre-intervention, periprocedurally

  3. 18-channel attended polysomnography (PSG)

    1. EEG (32-channel, 10-20 system) Sleep stage distribution: N1, N2, N3, REM (% and minutes per stage) Total Sleep Time (TST) Sleep Onset Latency (SOL) REM Latency Wake After Sleep Onset (WASO) Sleep Efficiency (TST / Time in Bed) Number of awakenings Arousal Index (EEG-defined arousals/hour, AASM criteria) Spontaneous (non-respiratory, non-limb) arousal count ii) EOG REM density iii) Submental EMG Atonia confirmation for REM staging Chin EMG tone, used jointly with EEG/EOG for arousal scoring iv) Bilateral anterior tibialis EMG Periodic Limb Movement Index (PLMI; events/hour) PLM Arousal Index (PLM events assoc. EEG arousal) v) ECG Heart Rate \& Variability across sleep stages vi) Nasal pressure + oronasal thermal airflow AHI vii) Thoracic + abdominal respiratory effort belt Obstructive vs. central, RERA → RDI viii) Pulse oximetry SpO2 nadir ODI, ≥3% or ≥4% threshold %TST < 90% ix) Snore sensor
    • TST snoring x) Body position sensor T/pos (supine, lateral, prone) Pos-dependent AHI

    Measured: periprocedurally*

  4. Actigraphy

    1. Steps/day ii) Distance/day iii) Heart rate (BPM)

    Measured: pre-intervention, periprocedurally

  5. Flanker Task

    EMA i) Reaction Time (RT) Mean/median RT (ms) / trial type x Congruent v. Incongruent trials Flanker Effect (or interference effect) = RT(incongruent) - RT(congruent)

    ii) Accuracy

    % correct x Congruent v. Incongruent Accuracy Interference Effect = accuracy(congruent) - accuracy(incongruent)

    Measured: pre-intervention, periprocedurally

  6. 2-Back Task

    EMA

    1. Hit Rate
    • correctly identified targets ii) Miss Rate
    • targets not identified iii) False Alarm Rate
    • non-target trials incorrectly identified as targets iv) Correct Rejection Rate
    • correctly identified non-targets
    1. d' (d-prime) z(hit rate) - z(false alarm rate) vi) c (criterion) or β (beta) response bias

    Measured: pre-intervention, periprocedurally

  7. Body Temperature

    1. Skin-surface (C/F) ii) Core (C/F) iii) Peripheral (C/F)

    Measured: pre-intervention, periprocedurally

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completionSep 2030 (estimated)
  4. Study completionSep 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Investigator
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07903896
Sponsor's protocol ID
HHC-2026-0022
Other IDs
323825/Z/24/Z
Status last verified
Oct 2026
First submitted
2 Oct 2026
Last updated
29 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified IPD from this study, together with data dictionaries and supporting documentation, will be deposited in the NIMH Data Archive (NDA). Shared data will include physiological measurements (core and peripheral temperature, heart rate), polysomnography and EEG-derived measures, actigraphy, environmental monitoring data, ecological momentary assessment responses, cognitive performance data, and clinical assessment scores. Direct identifiers and protected health information will be removed or aggregated prior to deposit. Analysis code will be shared via GitHub, and technical documentation - including detailed protocols, data dictionaries, standardized coding manuals, and quality-control procedures - will be posted on OSF.io.

Publications

  • Tubbs AS, Fernandez FX, Grandner MA, Perlis ML, Klerman EB. The Mind After Midnight: Nocturnal Wakefulness, Behavioral Dysregulation, and Psychopathology. Front Netw Physiol. 2022;1:830338. doi: 10.3389/fnetp.2021.830338. Epub 2022 Mar 3.

    PubMed 35538929
  • Hall M, Scherner PV, Kreidel Y, Rubel JA. A Systematic Review of Momentary Assessment Designs for Mood and Anxiety Symptoms. Front Psychol. 2021 May 17;12:642044. doi: 10.3389/fpsyg.2021.642044. eCollection 2021.

    PubMed 34079492
  • McGarr GW, Meade RD, Notley SR, Akerman AP, Richards BJ, McCourt ER, King KE, McCormick JJ, Boulay P, Sigal RJ, Kenny GP. Physiological responses to 9 hours of heat exposure in young and older adults. Part III: Association with self-reported symptoms and mood state. J Appl Physiol (1985). 2024 Feb 1;136(2):408-420. doi: 10.1152/japplphysiol.00740.2023. Epub 2023 Dec 28.

    PubMed 38153847
  • Chevance G, Minor K, Vielma C, Campi E, O'Callaghan-Gordo C, Basagana X, Ballester J, Bernard P. A systematic review of ambient heat and sleep in a warming climate. Sleep Med Rev. 2024 Jun;75:101915. doi: 10.1016/j.smrv.2024.101915. Epub 2024 Mar 6.

    PubMed 38598988
  • Fernandez-Sevillano J, Gonzalez-Pinto A, Rodriguez-Revuelta J, Alberich S, Gonzalez-Blanco L, Zorrilla I, Velasco A, Lopez MP, Abad I, Saiz PA. Suicidal behaviour and cognition: A systematic review with special focus on prefrontal deficits. J Affect Disord. 2021 Jan 1;278:488-496. doi: 10.1016/j.jad.2020.09.044. Epub 2020 Sep 13.

    PubMed 33017675
  • Akkaya-Kalayci T, Vyssoki B, Winkler D, Willeit M, Kapusta ND, Dorffner G, Ozlu-Erkilic Z. The effect of seasonal changes and climatic factors on suicide attempts of young people. BMC Psychiatry. 2017 Nov 15;17(1):365. doi: 10.1186/s12888-017-1532-7.

    PubMed 29141599
  • Bundo M, Preisig M, Merikangas K, Glaus J, Vaucher J, Waeber G, Marques-Vidal P, Strippoli MF, Muller T, Franco O, Vicedo-Cabrera AM. How ambient temperature affects mood: an ecological momentary assessment study in Switzerland. Environ Health. 2023 Jul 11;22(1):52. doi: 10.1186/s12940-023-01003-9.

    PubMed 37430261
  • Lohmus M. Possible Biological Mechanisms Linking Mental Health and Heat-A Contemplative Review. Int J Environ Res Public Health. 2018 Jul 18;15(7):1515. doi: 10.3390/ijerph15071515.

    PubMed 30021956

Questions about this trial

What is this clinical trial studying?

A study testing Heat/Humidity Exposure Condition and Thermoneutral Condition in people with Depressed Mood and Young Adults, run by Hartford Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 18 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Isaac C McAlister, PhD (860-545-7231, Isaac.McAlister@hhchealth.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PANAS-10 (time frame: periprocedurally* measures collected during lab weekends (i.e. periprocedurally) ONLY - marked with " * "). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07903896, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in